Donate Connect
SEARCH

FOP News

Ipsen Shares a Follow-Up Letter About the Termination of the FALKON Phase 2 Clinical Trial

Posted by · January 09, 2026 3:40 PM
Read more Share

Ipsen Issues an Important Announcement About the Results of the FALKON Trial

Posted by · December 19, 2025 8:04 AM
Read more Share

Medical Guidelines for FOP Published in JBMRPlus

Posted by · October 29, 2025 4:39 PM
Read more Share

Breaking News from Regeneron Regarding the OPTIMA Phase 3 Clinical Trial

Posted by · September 17, 2025 8:13 AM
Read more Share

ANDECAL Doses First Patient

Posted by · January 23, 2025 2:13 PM
Read more Share

Urge Your Senator to Renew the Priority Review Voucher (PRV) Program

Posted by · December 10, 2024 8:53 AM
Read more Share

UPenn's Dr. Eileen Shore Receives Prestigious Award from ASBMR

Posted by · August 30, 2024 4:00 PM
Read more Share

ICC Updates Their Statement on Off-Label Treatments

Posted by · August 20, 2024 8:22 AM
Read more Share

Regeneron's OPTIMA Phase 3 Clinical Trial is Full

Posted by · August 09, 2024 12:33 AM
Read more Share

ICC Releases 3rd Edition of the FOP Treatment Guidelines

Posted by · July 16, 2024 9:36 AM
Read more Share

Learn More

Is it FOP? Just Diagnosed Registry

Make a Difference

Donate Connect Fundraise
Sign in with Facebook, Twitter or email.
Site by Mosaic • Created with NationBuilder
Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter

X